ロード中...
In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and Potency
Background: Glypican 3 (GPC3), a plasma membrane heparan sulfate proteoglycan, is overexpressed on human hepatocellular carcinoma and may represent a promising biomarker. Several studies have reported peptides that selectively bind to GPC3 and could serve as scaffolds for imaging or therapeutic agen...
保存先:
| 出版年: | Cancer Biother Radiopharm |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mary Ann Liebert, Inc., publishers
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6802730/ https://ncbi.nlm.nih.gov/pubmed/31424293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2019.2888 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|